|
US4675189A
(en)
*
|
1980-11-18 |
1987-06-23 |
Syntex (U.S.A.) Inc. |
Microencapsulation of water soluble active polypeptides
|
|
US5366734A
(en)
*
|
1981-02-16 |
1994-11-22 |
Zeneca Limited |
Continuous release pharmaceutical compositions
|
|
CH660488A5
(en)
*
|
1982-12-17 |
1987-04-30 |
Sandoz Ag |
(Co)oligomeric hydroxycarboxylic acid derivatives, the preparation thereof, and the use thereof in pharmaceutical compositions
|
|
CA1196864A
(en)
*
|
1983-06-10 |
1985-11-19 |
Mattheus F.A. Goosen |
Controlled release of injectable and implantable insulin compositions
|
|
CH656884A5
(de)
*
|
1983-08-26 |
1986-07-31 |
Sandoz Ag |
Polyolester, deren herstellung und verwendung.
|
|
GB8416234D0
(en)
*
|
1984-06-26 |
1984-08-01 |
Ici Plc |
Biodegradable amphipathic copolymers
|
|
JPS6136321A
(ja)
*
|
1984-07-27 |
1986-02-21 |
Daicel Chem Ind Ltd |
新規なポリマ−およびその樹脂組成物
|
|
US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
|
KR890002631B1
(ko)
*
|
1984-10-04 |
1989-07-21 |
몬산토 캄파니 |
생물학적으로 활성인 소마토트로핀을 지속적으로 유리하는 조성물
|
|
US5411951A
(en)
*
|
1984-10-04 |
1995-05-02 |
Monsanto Company |
Prolonged release of biologically active somatotropin
|
|
US5474980A
(en)
*
|
1984-10-04 |
1995-12-12 |
Monsanto Company |
Prolonged release of biologically active somatotropins
|
|
EP0200757B1
(en)
*
|
1984-10-19 |
1992-03-11 |
Chiron Corporation |
Promotion of wound healing with human epidermal growth factor prepared from recombinant dna
|
|
US4895724A
(en)
*
|
1985-06-07 |
1990-01-23 |
Pfizer Inc. |
Chitosan compositions for controlled and prolonged release of macromolecules
|
|
US5036045A
(en)
*
|
1985-09-12 |
1991-07-30 |
The University Of Virginia Alumni Patents Foundation |
Method for increasing growth hormone secretion
|
|
US5102872A
(en)
*
|
1985-09-20 |
1992-04-07 |
Cetus Corporation |
Controlled-release formulations of interleukin-2
|
|
US4959217A
(en)
*
|
1986-05-22 |
1990-09-25 |
Syntex (U.S.A.) Inc. |
Delayed/sustained release of macromolecules
|
|
US4832686A
(en)
*
|
1986-06-24 |
1989-05-23 |
Anderson Mark E |
Method for administering interleukin-2
|
|
US4801457A
(en)
*
|
1986-08-01 |
1989-01-31 |
Sandoz Pharm. Corp. |
Polyacetal hydrogels formed from divinyl ethers and polyols
|
|
US4882168A
(en)
*
|
1986-09-05 |
1989-11-21 |
American Cyanamid Company |
Polyesters containing alkylene oxide blocks as drug delivery systems
|
|
JPH0725689B2
(ja)
*
|
1986-10-07 |
1995-03-22 |
中外製薬株式会社 |
顆粒球コロニ−刺激因子を含有する徐放性製剤
|
|
US5075109A
(en)
*
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
|
US6024983A
(en)
*
|
1986-10-24 |
2000-02-15 |
Southern Research Institute |
Composition for delivering bioactive agents for immune response and its preparation
|
|
US5037644A
(en)
*
|
1986-10-27 |
1991-08-06 |
Cetus Corporation |
Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
|
|
US5183746A
(en)
*
|
1986-10-27 |
1993-02-02 |
Schering Aktiengesellschaft |
Formulation processes for pharmaceutical compositions of recombinant β-
|
|
US5688519A
(en)
*
|
1987-04-06 |
1997-11-18 |
Leonard; Robert J. |
Flash-flow fused medicinal implants
|
|
US5000886A
(en)
*
|
1987-05-26 |
1991-03-19 |
American Cyanamid Company |
Silicone-hardened pharmaceutical microcapsules and process of making the same
|
|
US5938654A
(en)
*
|
1987-06-25 |
1999-08-17 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
|
US5340590A
(en)
*
|
1987-06-25 |
1994-08-23 |
Alza Corporation |
Delivery system with bilayer osmotic engine
|
|
US5236689A
(en)
*
|
1987-06-25 |
1993-08-17 |
Alza Corporation |
Multi-unit delivery system
|
|
US5391381A
(en)
*
|
1987-06-25 |
1995-02-21 |
Alza Corporation |
Dispenser capable of delivering plurality of drug units
|
|
US4992418A
(en)
*
|
1987-07-17 |
1991-02-12 |
Mount Sinai School Of Medicine |
Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
|
|
GB2209937B
(en)
*
|
1987-09-21 |
1991-07-03 |
Depiopharm S A |
Water insoluble polypeptides
|
|
US5017560A
(en)
*
|
1987-11-06 |
1991-05-21 |
Pitman-Moore, Inc. |
Poultry growth promotion
|
|
US5004605A
(en)
*
|
1987-12-10 |
1991-04-02 |
Cetus Corporation |
Low pH pharmaceutical compositions of recombinant β-interferon
|
|
JPH01163135A
(ja)
*
|
1987-12-18 |
1989-06-27 |
Taki Chem Co Ltd |
徐放性基剤の製造方法
|
|
GB8801863D0
(en)
*
|
1988-01-28 |
1988-02-24 |
Fulmer Yarsley Ltd |
Pharmaceutical formulations with controlled drug release
|
|
US5137669A
(en)
*
|
1988-03-02 |
1992-08-11 |
Endocon, Inc. |
Manufacture of partially fused peptide pellet
|
|
US4959218A
(en)
*
|
1988-03-25 |
1990-09-25 |
Alza Corporation |
Method for delivering somatotropin to an animal
|
|
US4996060A
(en)
*
|
1988-03-25 |
1991-02-26 |
Alza Corporation |
Device comprising liner for protecting fluid sensitive medicament
|
|
US5078997A
(en)
*
|
1988-07-13 |
1992-01-07 |
Cetus Corporation |
Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
|
|
US5216050A
(en)
*
|
1988-08-08 |
1993-06-01 |
Biopak Technology, Ltd. |
Blends of polyactic acid
|
|
US5252642A
(en)
*
|
1989-03-01 |
1993-10-12 |
Biopak Technology, Ltd. |
Degradable impact modified polyactic acid
|
|
US5444113A
(en)
*
|
1988-08-08 |
1995-08-22 |
Ecopol, Llc |
End use applications of biodegradable polymers
|
|
US4925677A
(en)
*
|
1988-08-31 |
1990-05-15 |
Theratech, Inc. |
Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
|
|
JPH064540B2
(ja)
*
|
1988-09-14 |
1994-01-19 |
多木化学株式会社 |
医用組成物
|
|
US5057318A
(en)
*
|
1988-12-13 |
1991-10-15 |
Alza Corporation |
Delivery system for beneficial agent over a broad range of rates
|
|
US5059423A
(en)
*
|
1988-12-13 |
1991-10-22 |
Alza Corporation |
Delivery system comprising biocompatible beneficial agent formulation
|
|
US5037420A
(en)
*
|
1988-12-13 |
1991-08-06 |
Alza Corporation |
Delivery system comprising two sections for delivering somatotropin
|
|
US5110596A
(en)
*
|
1988-12-13 |
1992-05-05 |
Alza Corporation |
Delivery system comprising means for delivering agent to livestock
|
|
US5034229A
(en)
*
|
1988-12-13 |
1991-07-23 |
Alza Corporation |
Dispenser for increasing feed conversion of hog
|
|
US5135523A
(en)
*
|
1988-12-13 |
1992-08-04 |
Alza Corporation |
Delivery system for administering agent to ruminants and swine
|
|
US5174999A
(en)
*
|
1988-12-13 |
1992-12-29 |
Alza Corporation |
Delivery system comprising fluid ingress and drug egress
|
|
US5728088A
(en)
*
|
1988-12-13 |
1998-03-17 |
Alza Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
|
|
US4990336A
(en)
*
|
1989-02-08 |
1991-02-05 |
Biosearch, Inc. |
Sustained release dosage form
|
|
DE68915784T2
(de)
*
|
1989-03-09 |
1994-09-29 |
Endocom, Inc., Boston, Mass. |
Teilweise geschmolzenes peptidpellet.
|
|
PH30995A
(en)
*
|
1989-07-07 |
1997-12-23 |
Novartis Inc |
Sustained release formulations of water soluble peptides.
|
|
US5538739A
(en)
*
|
1989-07-07 |
1996-07-23 |
Sandoz Ltd. |
Sustained release formulations of water soluble peptides
|
|
HU221294B1
(en)
*
|
1989-07-07 |
2002-09-28 |
Novartis Ag |
Process for producing retarde compositions containing the active ingredient in a polymeric carrier
|
|
US5487897A
(en)
*
|
1989-07-24 |
1996-01-30 |
Atrix Laboratories, Inc. |
Biodegradable implant precursor
|
|
US5324519A
(en)
*
|
1989-07-24 |
1994-06-28 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
|
US5225205A
(en)
*
|
1989-07-28 |
1993-07-06 |
Debiopharm S.A. |
Pharmaceutical composition in the form of microparticles
|
|
EP0423484B1
(de)
*
|
1989-10-16 |
1993-11-03 |
PCD-Polymere Gesellschaft m.b.H. |
Pressling mit retardierter Wirkstofffreisetzung
|
|
DE3935736A1
(de)
*
|
1989-10-27 |
1991-05-02 |
Chemie Linz Deutschland |
Pressling mit retardierter wirkstofffreisetzung
|
|
US5126147A
(en)
*
|
1990-02-08 |
1992-06-30 |
Biosearch, Inc. |
Sustained release dosage form
|
|
US6552170B1
(en)
|
1990-04-06 |
2003-04-22 |
Amgen Inc. |
PEGylation reagents and compounds formed therewith
|
|
US5091185A
(en)
*
|
1990-06-20 |
1992-02-25 |
Monsanto Company |
Coated veterinary implants
|
|
US5360892A
(en)
*
|
1990-06-26 |
1994-11-01 |
Arch Development Corporation |
Water and UV degradable lactic acid polymers
|
|
US5234692A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
|
US5234694A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Method for increasing feed efficiency in animals
|
|
US5234693A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
|
US5238687A
(en)
*
|
1990-07-11 |
1993-08-24 |
Alza Corporation |
Delivery device with a protective sleeve
|
|
US5180591A
(en)
*
|
1990-07-11 |
1993-01-19 |
Alza Corporation |
Delivery device with a protective sleeve
|
|
IE912365A1
(en)
*
|
1990-07-23 |
1992-01-29 |
Zeneca Ltd |
Continuous release pharmaceutical compositions
|
|
US6353030B1
(en)
*
|
1990-08-01 |
2002-03-05 |
Novartis Ag |
Relating to organic compounds
|
|
US5626863A
(en)
*
|
1992-02-28 |
1997-05-06 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
|
US5462990A
(en)
*
|
1990-10-15 |
1995-10-31 |
Board Of Regents, The University Of Texas System |
Multifunctional organic polymers
|
|
US5410016A
(en)
*
|
1990-10-15 |
1995-04-25 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
|
IT1243390B
(it)
*
|
1990-11-22 |
1994-06-10 |
Vectorpharma Int |
Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
|
|
US5443459A
(en)
*
|
1991-01-30 |
1995-08-22 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
|
US5861166A
(en)
*
|
1991-03-12 |
1999-01-19 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
|
EP0584220A1
(en)
*
|
1991-05-14 |
1994-03-02 |
Endocon, Inc. |
Engineering the local inflammatory response as a means of controlled release drug delivery
|
|
US5137727A
(en)
*
|
1991-06-12 |
1992-08-11 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
|
FR2678168B1
(fr)
|
1991-06-28 |
1993-09-03 |
Rhone Poulenc Rorer Sa |
Nanoparticules ayant un temps de capture par le dysteme reticulo endothelial allonge.
|
|
EP0596123A4
(en)
*
|
1991-10-31 |
1995-03-29 |
Kobe Steel Ltd |
BIODEGRADABLE PLASTIC MATERIAL.
|
|
DE69329594T2
(de)
*
|
1992-02-28 |
2001-05-31 |
Board Of Regents, The University Of Texas System |
Photopolymerinierbare, biologisch abbaubare hydrogele als gewebekontaktmaterialien und trägerstoffe für kontrollierte freisetzung
|
|
US5573934A
(en)
*
|
1992-04-20 |
1996-11-12 |
Board Of Regents, The University Of Texas System |
Gels for encapsulation of biological materials
|
|
US5352515A
(en)
*
|
1992-03-02 |
1994-10-04 |
American Cyanamid Company |
Coating for tissue drag reduction
|
|
US5518730A
(en)
|
1992-06-03 |
1996-05-21 |
Fuisz Technologies Ltd. |
Biodegradable controlled release flash flow melt-spun delivery system
|
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
US5981719A
(en)
*
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
KR960015447B1
(ko)
*
|
1993-03-16 |
1996-11-14 |
주식회사 삼양사 |
의료용 생분해성 고분자
|
|
HU225496B1
(en)
*
|
1993-04-07 |
2007-01-29 |
Scios Inc |
Pharmaceutical compositions of prolonged delivery, containing peptides
|
|
US6284727B1
(en)
|
1993-04-07 |
2001-09-04 |
Scios, Inc. |
Prolonged delivery of peptides
|
|
US20050181976A1
(en)
*
|
1993-05-10 |
2005-08-18 |
Ekwuribe Nnochiri N. |
Amphiphilic oligomers
|
|
US6191105B1
(en)
*
|
1993-05-10 |
2001-02-20 |
Protein Delivery, Inc. |
Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
|
|
US5359030A
(en)
*
|
1993-05-10 |
1994-10-25 |
Protein Delivery, Inc. |
Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
|
|
US5522841A
(en)
*
|
1993-05-27 |
1996-06-04 |
United States Surgical Corporation |
Absorbable block copolymers and surgical articles fabricated therefrom
|
|
JP3220331B2
(ja)
*
|
1993-07-20 |
2001-10-22 |
エチコン・インコーポレーテツド |
非経口投与用の吸収性液体コポリマー類
|
|
US5565215A
(en)
*
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
|
US5543158A
(en)
*
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
EP0712421A1
(en)
*
|
1993-07-23 |
1996-05-22 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
|
US5876438A
(en)
*
|
1993-08-02 |
1999-03-02 |
Houston Biotechnology Incorporated |
Polymeric device for the delivery of immunotoxins for the prevention of secondary cataract
|
|
US5563238A
(en)
*
|
1993-08-05 |
1996-10-08 |
Arch Development Corporation |
Water and UV degradable lactic acid polymers
|
|
KR0148704B1
(ko)
*
|
1994-01-10 |
1998-08-17 |
김상응 |
생체분해성 약물전달용 고분자
|
|
US5569468A
(en)
*
|
1994-02-17 |
1996-10-29 |
Modi; Pankaj |
Vaccine delivery system for immunization, using biodegradable polymer microspheres
|
|
US5417982A
(en)
*
|
1994-02-17 |
1995-05-23 |
Modi; Pankaj |
Controlled release of drugs or hormones in biodegradable polymer microspheres
|
|
US5527271A
(en)
*
|
1994-03-30 |
1996-06-18 |
Bristol-Myers Squibb Co. |
Thermoplastic hydrogel impregnated composite material
|
|
KR0141431B1
(ko)
*
|
1994-05-17 |
1998-07-01 |
김상웅 |
생분해성 하이드로겔 고분자
|
|
GB9412273D0
(en)
*
|
1994-06-18 |
1994-08-10 |
Univ Nottingham |
Administration means
|
|
US6007845A
(en)
*
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
|
US6063116A
(en)
*
|
1994-10-26 |
2000-05-16 |
Medarex, Inc. |
Modulation of cell proliferation and wound healing
|
|
US5714573A
(en)
*
|
1995-01-19 |
1998-02-03 |
Cargill, Incorporated |
Impact modified melt-stable lactide polymer compositions and processes for manufacture thereof
|
|
US5618850A
(en)
*
|
1995-03-09 |
1997-04-08 |
Focal, Inc. |
Hydroxy-acid cosmetics
|
|
US5955159A
(en)
*
|
1995-03-15 |
1999-09-21 |
Acushnet Company |
Conforming shoe construction using gels and method of making the same
|
|
US5939157A
(en)
*
|
1995-10-30 |
1999-08-17 |
Acushnet Company |
Conforming shoe construction using gels and method of making the same
|
|
US5985383A
(en)
*
|
1995-03-15 |
1999-11-16 |
Acushnet Company |
Conforming shoe construction and gel compositions therefor
|
|
WO1996029987A1
(en)
|
1995-03-24 |
1996-10-03 |
Focal, Inc. |
Reduction of adhesions using controlled delivery of active oxygen inhibitors
|
|
US5612052A
(en)
*
|
1995-04-13 |
1997-03-18 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
|
US6413539B1
(en)
|
1996-10-31 |
2002-07-02 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
|
US5690952A
(en)
*
|
1995-06-07 |
1997-11-25 |
Judy A. Magruder et al. |
Implantable system for delivery of fluid-sensitive agents to animals
|
|
US5904935A
(en)
*
|
1995-06-07 |
1999-05-18 |
Alza Corporation |
Peptide/protein suspending formulations
|
|
NZ309662A
(en)
*
|
1995-06-12 |
1998-09-24 |
Bernard Technologies Inc |
Sustained release biocidal composition containing an acid releasing polymer, a hydrophilic material and chlorite ions
|
|
CA2228118A1
(en)
|
1995-07-28 |
1997-02-13 |
Focal, Inc. |
Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatments agents
|
|
KR0180334B1
(ko)
*
|
1995-09-21 |
1999-03-20 |
김윤 |
블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
|
|
US5773019A
(en)
*
|
1995-09-27 |
1998-06-30 |
The University Of Kentucky Research Foundation |
Implantable controlled release device to deliver drugs directly to an internal portion of the body
|
|
US5665428A
(en)
*
|
1995-10-25 |
1997-09-09 |
Macromed, Inc. |
Preparation of peptide containing biodegradable microspheres by melt process
|
|
US5702717A
(en)
*
|
1995-10-25 |
1997-12-30 |
Macromed, Inc. |
Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
|
|
US5766704A
(en)
*
|
1995-10-27 |
1998-06-16 |
Acushnet Company |
Conforming shoe construction and gel compositions therefor
|
|
FR2741628B1
(fr)
*
|
1995-11-29 |
1998-02-06 |
Centre Nat Rech Scient |
Nouveaux hydrogels a base de copolymeres trisequences et leur application notamment a la liberation progressive de principes actifs
|
|
US5611344A
(en)
*
|
1996-03-05 |
1997-03-18 |
Acusphere, Inc. |
Microencapsulated fluorinated gases for use as imaging agents
|
|
ATE302599T1
(de)
*
|
1996-05-24 |
2005-09-15 |
Angiotech Pharm Inc |
Zubereitungen und verfahren zur behandlung oder prävention von krankheiten der körperpassagewege
|
|
TW555765B
(en)
|
1996-07-09 |
2003-10-01 |
Amgen Inc |
Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
|
|
US5756651A
(en)
*
|
1996-07-17 |
1998-05-26 |
Chronopol, Inc. |
Impact modified polylactide
|
|
US5837221A
(en)
*
|
1996-07-29 |
1998-11-17 |
Acusphere, Inc. |
Polymer-lipid microencapsulated gases for use as imaging agents
|
|
ZA978537B
(en)
|
1996-09-23 |
1998-05-12 |
Focal Inc |
Polymerizable biodegradable polymers including carbonate or dioxanone linkages.
|
|
US6191236B1
(en)
|
1996-10-11 |
2001-02-20 |
United States Surgical Corporation |
Bioabsorbable suture and method of its manufacture
|
|
US5968895A
(en)
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
|
US20070185032A1
(en)
*
|
1996-12-11 |
2007-08-09 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
|
ZA9711385B
(en)
*
|
1996-12-20 |
1999-06-18 |
Takeda Chemical Industries Ltd |
Method of producing a sustained-release preparation
|
|
CA2274676A1
(en)
|
1996-12-31 |
1998-07-09 |
James Hongxue Wang |
Water-responsive polymer compositions and method of making the same
|
|
US6402520B1
(en)
*
|
1997-04-30 |
2002-06-11 |
Unique Logic And Technology, Inc. |
Electroencephalograph based biofeedback system for improving learning skills
|
|
CA2291622C
(en)
|
1997-06-06 |
2007-09-04 |
Anna Gutowska |
Reversible geling co-polymer and method of making
|
|
US5945480A
(en)
*
|
1997-07-31 |
1999-08-31 |
Kimberly-Clark Worldwide, Inc. |
Water-responsive, biodegradable fibers comprising polylactide modified polylactide and polyvinyl alcohol, and method for making the fibers
|
|
US6552162B1
(en)
|
1997-07-31 |
2003-04-22 |
Kimberly-Clark Worldwide, Inc. |
Water-responsive, biodegradable compositions and films and articles comprising a blend of polylactide and polyvinyl alcohol and methods for making the same
|
|
US6075118A
(en)
*
|
1997-07-31 |
2000-06-13 |
Kimberly-Clark Worldwide, Inc. |
Water-responsive, biodegradable film compositions comprising polylactide and polyvinyl alcohol, and a method for making the films
|
|
US5952433A
(en)
*
|
1997-07-31 |
1999-09-14 |
Kimberly-Clark Worldwide, Inc. |
Modified polyactide compositions and a reactive-extrusion process to make the same
|
|
JP2001517603A
(ja)
*
|
1997-08-08 |
2001-10-09 |
ユニバーシティ オブ ユタ リサーチ ファウンデイション |
薬物送達における使用のための注射可能な生分解性ブロックコポリマーゲル
|
|
US5852117A
(en)
*
|
1997-08-26 |
1998-12-22 |
National Starch And Chemical Investment Holding Corporation |
Process for making lactide graft copolymers
|
|
US6007565A
(en)
*
|
1997-09-05 |
1999-12-28 |
United States Surgical |
Absorbable block copolymers and surgical articles fabricated therefrom
|
|
US6004573A
(en)
*
|
1997-10-03 |
1999-12-21 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
US6117949A
(en)
*
|
1998-10-01 |
2000-09-12 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
US6201072B1
(en)
*
|
1997-10-03 |
2001-03-13 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
US20020164374A1
(en)
*
|
1997-10-29 |
2002-11-07 |
John Jackson |
Polymeric systems for drug delivery and uses thereof
|
|
US6277927B1
(en)
|
1997-11-26 |
2001-08-21 |
United States Surgical Corporation |
Absorbable block copolymers and surgical articles fabricated therefrom
|
|
US6613358B2
(en)
|
1998-03-18 |
2003-09-02 |
Theodore W. Randolph |
Sustained-release composition including amorphous polymer
|
|
WO1999047543A2
(en)
*
|
1998-03-18 |
1999-09-23 |
University Technology Corporation |
Sustained-release composition including amorphous polymer
|
|
ES2359973T3
(es)
|
1998-03-19 |
2011-05-30 |
MERCK SHARP & DOHME CORP. |
Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
|
|
NZ506415A
(en)
*
|
1998-03-19 |
2003-06-30 |
Merck & Co Inc |
Liquid polymeric compositions for controlled release of bioactive substances using a polymer to active agent ratio of less than 1:1
|
|
DE19812688A1
(de)
*
|
1998-03-23 |
1999-09-30 |
Basf Ag |
Verfahren zur Herstellung von festen Dosierungsformen
|
|
US20040228794A1
(en)
*
|
1998-04-10 |
2004-11-18 |
Battelle Memorial Institute |
Therapeutic agent carrier compositions
|
|
US6841617B2
(en)
*
|
2000-09-28 |
2005-01-11 |
Battelle Memorial Institute |
Thermogelling biodegradable aqueous polymer solution
|
|
US7087244B2
(en)
*
|
2000-09-28 |
2006-08-08 |
Battelle Memorial Institute |
Thermogelling oligopeptide polymers
|
|
US7128927B1
(en)
|
1998-04-14 |
2006-10-31 |
Qlt Usa, Inc. |
Emulsions for in-situ delivery systems
|
|
US6350518B1
(en)
|
1998-06-01 |
2002-02-26 |
Kimberly-Clark Worldwide, Inc. |
Methods of making blend compositions of an unmodified poly vinyl alcohol and a thermoplastic elastomer
|
|
CA2338319A1
(en)
*
|
1998-07-21 |
2000-02-03 |
Monsanto Company |
Clarification of protein precipitate suspensions using anionic polymeric flocculants
|
|
US7662409B2
(en)
*
|
1998-09-25 |
2010-02-16 |
Gel-Del Technologies, Inc. |
Protein matrix materials, devices and methods of making and using thereof
|
|
US20050147690A1
(en)
*
|
1998-09-25 |
2005-07-07 |
Masters David B. |
Biocompatible protein particles, particle devices and methods thereof
|
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
US6143314A
(en)
*
|
1998-10-28 |
2000-11-07 |
Atrix Laboratories, Inc. |
Controlled release liquid delivery compositions with low initial drug burst
|
|
US6451346B1
(en)
*
|
1998-12-23 |
2002-09-17 |
Amgen Inc |
Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents
|
|
JP4865947B2
(ja)
*
|
1999-02-19 |
2012-02-01 |
ウニフェルシテイト ユトレヒト |
ステレオコンプレックスヒドロゲル
|
|
JP4548623B2
(ja)
|
1999-02-24 |
2010-09-22 |
多木化学株式会社 |
生体材料
|
|
AU3556400A
(en)
|
1999-03-17 |
2000-10-04 |
Novartis Ag |
Pharmaceutical compositions
|
|
US6217630B1
(en)
|
1999-05-03 |
2001-04-17 |
Cargill, Incorporated |
Conditioned fertilizer product, method for conditioning fertilizer, and method for using conditioned fertilizer product
|
|
WO2000071602A1
(en)
*
|
1999-05-19 |
2000-11-30 |
Nof Corporation |
Polymer, in vivo degradable material, and use
|
|
US7169889B1
(en)
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
|
US6521431B1
(en)
|
1999-06-22 |
2003-02-18 |
Access Pharmaceuticals, Inc. |
Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
|
|
US7052711B2
(en)
*
|
1999-09-02 |
2006-05-30 |
Rice University |
Nitric oxide-producing hydrogel materials
|
|
US7279176B1
(en)
|
1999-09-02 |
2007-10-09 |
Rice University |
Nitric oxide-producing hydrogel materials
|
|
US8226598B2
(en)
*
|
1999-09-24 |
2012-07-24 |
Tolmar Therapeutics, Inc. |
Coupling syringe system and methods for obtaining a mixed composition
|
|
AU785038B2
(en)
*
|
2000-01-27 |
2006-08-31 |
Applied Molecular Evolution, Inc. |
Ultra high affinity neutralizing antibodies
|
|
US7229619B1
(en)
|
2000-11-28 |
2007-06-12 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
|
JP2003525090A
(ja)
*
|
2000-03-01 |
2003-08-26 |
グラクソ グループ リミテッド |
定量噴霧式吸入器
|
|
EP2341075A1
(en)
*
|
2000-03-01 |
2011-07-06 |
MedImmune, LLC |
Antibodies binding to the f protein of a respiratory syncytial virus (rsv)
|
|
US7193007B2
(en)
*
|
2000-03-15 |
2007-03-20 |
Yu-Ling Cheng |
Environment responsive gelling copolymer
|
|
US7018645B1
(en)
|
2000-04-27 |
2006-03-28 |
Macromed, Inc. |
Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
|
|
EP1291023A1
(en)
*
|
2000-06-14 |
2003-03-12 |
Takeda Chemical Industries, Ltd. |
Sustained release compositions
|
|
US20040062815A1
(en)
*
|
2000-06-29 |
2004-04-01 |
Gerd Fricker |
Bdellosomes
|
|
US6338859B1
(en)
*
|
2000-06-29 |
2002-01-15 |
Labopharm Inc. |
Polymeric micelle compositions
|
|
KR100451910B1
(ko)
*
|
2000-10-05 |
2004-10-08 |
주식회사 바이오폴리테크 |
수용성 생체분해성 고분자 겔 및 그의 제조방법
|
|
DE10055742B4
(de)
*
|
2000-11-10 |
2006-05-11 |
Schwarz Pharma Ag |
Neue Polyester, Verfahren zu ihrer Herstellung und aus den Polyestern hergestellte Depot-Arzneiformen
|
|
US6818216B2
(en)
*
|
2000-11-28 |
2004-11-16 |
Medimmune, Inc. |
Anti-RSV antibodies
|
|
TWI327600B
(en)
|
2000-11-28 |
2010-07-21 |
Medimmune Llc |
Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment
|
|
US6855493B2
(en)
*
|
2000-11-28 |
2005-02-15 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
|
US7179900B2
(en)
*
|
2000-11-28 |
2007-02-20 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
|
EP1355919B1
(en)
|
2000-12-12 |
2010-11-24 |
MedImmune, LLC |
Molecules with extended half-lives, compositions and uses thereof
|
|
JP4986370B2
(ja)
|
2000-12-22 |
2012-07-25 |
マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ |
Ｒｇｍおよびそのモジュレーターの用途
|
|
EP1347756B1
(en)
|
2000-12-27 |
2006-03-08 |
Genzyme Corporation |
Controlled release of anti-arrhythmic agents from a biodegradable hydrogel for local application to the heart
|
|
US7060675B2
(en)
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
|
WO2002069904A2
(en)
*
|
2001-03-02 |
2002-09-12 |
Medimmune, Inc. |
Cd2 antagonists for treatment of autoimmune or inflammatory disease
|
|
DE10111767B4
(de)
*
|
2001-03-12 |
2005-03-24 |
Schwarz Pharma Ag |
Verfahren zur Herstellung von Polyestern aus Hydroxycarbonsäuren und Polyolen durch Polykondensation
|
|
US20030157170A1
(en)
*
|
2001-03-13 |
2003-08-21 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
|
EP1418945A2
(en)
*
|
2001-03-13 |
2004-05-19 |
Angiotech Pharmaceuticals, Inc. |
Micellar drug delivery vehicles and uses thereof
|
|
US20040185101A1
(en)
*
|
2001-03-27 |
2004-09-23 |
Macromed, Incorporated. |
Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof
|
|
DK1392254T3
(da)
*
|
2001-04-20 |
2007-07-02 |
Univ British Columbia |
Micelle-lægemiddelindgivelsessystem for hydrofobe lægemidler
|
|
US6835802B2
(en)
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
|
US7713932B2
(en)
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
|
US6939564B2
(en)
*
|
2001-06-08 |
2005-09-06 |
Labopharm, Inc. |
Water-soluble stabilized self-assembled polyelectrolytes
|
|
WO2003000156A1
(en)
*
|
2001-06-22 |
2003-01-03 |
Southern Biosystems, Inc. |
Zero-order prolonged release coaxial implants
|
|
KR20040017297A
(ko)
*
|
2001-07-13 |
2004-02-26 |
메비올 가부시키가이샤 |
조직·장기 재생용 재료 및 조직·장기 재생 방법
|
|
US7309498B2
(en)
*
|
2001-10-10 |
2007-12-18 |
Belenkaya Bronislava G |
Biodegradable absorbents and methods of preparation
|
|
CA2466998A1
(en)
*
|
2001-11-12 |
2003-05-22 |
Alkermes Controlled Therapeutics, Inc. |
Biocompatible polymer blends and uses thereof
|
|
US7763663B2
(en)
*
|
2001-12-19 |
2010-07-27 |
University Of Massachusetts |
Polysaccharide-containing block copolymer particles and uses thereof
|
|
KR100978905B1
(ko)
*
|
2002-03-14 |
2010-08-31 |
가부시키가이샤 메드렉스 |
창상용 외용제
|
|
US7018655B2
(en)
*
|
2002-03-18 |
2006-03-28 |
Labopharm, Inc. |
Amphiphilic diblock, triblock and star-block copolymers and their pharmaceutical compositions
|
|
AU2003225212A1
(en)
*
|
2002-04-29 |
2003-11-17 |
Gel-Del Technologies, Inc. |
Biomatrix structural containment and fixation systems and methods of use thereof
|
|
US20030228366A1
(en)
*
|
2002-06-11 |
2003-12-11 |
Chung Shih |
Reconstitutable compositions of biodegradable block copolymers
|
|
US7649023B2
(en)
*
|
2002-06-11 |
2010-01-19 |
Novartis Ag |
Biodegradable block copolymeric compositions for drug delivery
|
|
US7132100B2
(en)
|
2002-06-14 |
2006-11-07 |
Medimmune, Inc. |
Stabilized liquid anti-RSV antibody formulations
|
|
US7425618B2
(en)
*
|
2002-06-14 |
2008-09-16 |
Medimmune, Inc. |
Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
|
|
WO2004010935A2
(en)
*
|
2002-07-25 |
2004-02-05 |
Medimmune, Inc. |
Methods of treating and preventing rsv, hmpv, and piv using anti-rsv, anti-hmpv, and anti-piv antibodies
|
|
ES2381617T5
(es)
|
2002-08-14 |
2016-02-24 |
Macrogenics, Inc. |
Anticuerpos específicos frente a FcgammaRIIB y sus procedimientos de uso
|
|
JP4596916B2
(ja)
*
|
2002-09-05 |
2010-12-15 |
メディミューン，エルエルシー |
Ｃｄ２拮抗薬を投与することによりｔ細胞悪性腫瘍を予防または治療する方法
|
|
CN104383554B
(zh)
|
2002-09-06 |
2018-06-08 |
天蓝制药公司 |
用于传递治疗剂的以环糊精为基础的聚合物
|
|
US20060069168A1
(en)
*
|
2002-10-29 |
2006-03-30 |
Norikazu Tabata |
Vascular embolization material
|
|
US7407672B2
(en)
*
|
2002-11-04 |
2008-08-05 |
National Heart Center |
Composition derived from biological materials and method of use and preparation
|
|
AU2003285200A1
(en)
*
|
2002-11-09 |
2004-06-03 |
Nobex Corporation |
Modified carbamate-containing prodrugs and methods of synthesizing same
|
|
US7648962B2
(en)
*
|
2002-11-26 |
2010-01-19 |
Biocon Limited |
Natriuretic compounds, conjugates, and uses thereof
|
|
CA2504287A1
(en)
|
2002-11-26 |
2004-06-10 |
Nobex Corporation |
Natriuretic compounds, conjugates, and uses thereof
|
|
AU2004204494B2
(en)
|
2003-01-09 |
2011-09-29 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
|
JP2007525149A
(ja)
|
2003-01-13 |
2007-09-06 |
マクロジェニクス，インコーポレーテッド |
可溶性ＦｃγＲ融合タンパク質およびその使用法
|
|
US20040208869A1
(en)
*
|
2003-01-30 |
2004-10-21 |
Medimmune, Inc. |
Uses of anti-integrin alphanubeta3 antibody formulations
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
WO2004091510A2
(en)
|
2003-04-11 |
2004-10-28 |
Medimmune, Inc. |
Recombinant il-9 antibodies and uses thereof
|
|
US20060193825A1
(en)
*
|
2003-04-29 |
2006-08-31 |
Praecis Phamaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
|
US20050112087A1
(en)
*
|
2003-04-29 |
2005-05-26 |
Musso Gary F. |
Pharmaceutical formulations for sustained drug delivery
|
|
US8465537B2
(en)
*
|
2003-06-17 |
2013-06-18 |
Gel-Del Technologies, Inc. |
Encapsulated or coated stent systems
|
|
US7326571B2
(en)
*
|
2003-07-17 |
2008-02-05 |
Boston Scientific Scimed, Inc. |
Decellularized bone marrow extracellular matrix
|
|
US20050013870A1
(en)
*
|
2003-07-17 |
2005-01-20 |
Toby Freyman |
Decellularized extracellular matrix of conditioned body tissues and uses thereof
|
|
US20060228350A1
(en)
*
|
2003-08-18 |
2006-10-12 |
Medimmune, Inc. |
Framework-shuffling of antibodies
|
|
WO2005042743A2
(en)
|
2003-08-18 |
2005-05-12 |
Medimmune, Inc. |
Humanization of antibodies
|
|
US8153591B2
(en)
*
|
2003-08-26 |
2012-04-10 |
Gel-Del Technologies, Inc. |
Protein biomaterials and biocoacervates and methods of making and using thereof
|
|
ITMI20031872A1
(it)
*
|
2003-09-30 |
2005-04-01 |
Mediolanum Farmaceutici Srl |
Copolimeri di poliesteri e polivinilpirrolidone.
|
|
JP4440888B2
(ja)
*
|
2003-11-04 |
2010-03-24 |
スプラポリックス・ビー．ブイ． |
重合体幹内に４重水素結合単位を含む超分子重合体の製造
|
|
US20060053516A1
(en)
*
|
2003-12-05 |
2006-03-09 |
The University Of Hong Kong |
Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS
|
|
CA2548822C
(en)
*
|
2003-12-08 |
2015-08-11 |
Gel-Del Technologies, Inc. |
Mucoadhesive drug delivery devices and methods of making and using thereof
|
|
EP1711159B1
(en)
|
2003-12-30 |
2013-03-20 |
Durect Corporation |
Solid implants containing a block copolymer for controlled release of a gnrh compound
|
|
KR20050077916A
(ko)
|
2004-01-29 |
2005-08-04 |
학교법인 성균관대학 |
ｐＨ 및 온도 민감성 하이드로겔
|
|
RU2006142851A
(ru)
*
|
2004-05-05 |
2008-06-10 |
Фирмениш Са (Ch) |
Биодеградируемые привитые сополимеры
|
|
WO2005115489A2
(en)
*
|
2004-05-24 |
2005-12-08 |
Genzyme Corporation |
Adherent polymeric compositions
|
|
US8012457B2
(en)
|
2004-06-04 |
2011-09-06 |
Acusphere, Inc. |
Ultrasound contrast agent dosage formulation
|
|
WO2005120462A2
(en)
*
|
2004-06-07 |
2005-12-22 |
Callisyn Pharmaceuticals, Inc. |
Biodegradable and biocompatible crosslinked polymer hydrogel prepared from pva and/or peg macromer mixtures
|
|
US20060004185A1
(en)
*
|
2004-07-01 |
2006-01-05 |
Leese Richard A |
Peptide antibiotics and peptide intermediates for their prepartion
|
|
WO2006006855A1
(en)
*
|
2004-07-12 |
2006-01-19 |
Suprapolix B.V. |
Supramolecular ionomers
|
|
EP1778268B1
(en)
|
2004-07-21 |
2016-05-04 |
Tulane University Health Sciences Center |
Treatment of renal dysfunction and multiple myeloma using pacap compounds
|
|
US8357391B2
(en)
*
|
2004-07-30 |
2013-01-22 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages
|
|
US20060034889A1
(en)
*
|
2004-08-16 |
2006-02-16 |
Macromed, Inc. |
Biodegradable diblock copolymers having reverse thermal gelation properties and methods of use thereof
|
|
EP1809326A4
(en)
|
2004-10-27 |
2009-11-04 |
Medimmune Inc |
MODULATION OF ANTIBODY SPECIFICITY BY MEASURING ADAPTATION OF ITS AFFINITY TO AN APPARENT ANTIGEN
|
|
AU2005302453A1
(en)
*
|
2004-10-29 |
2006-05-11 |
Medimmune, Llc |
Methods of preventing and treating RSV infections and related conditions
|
|
US20060149363A1
(en)
*
|
2005-01-06 |
2006-07-06 |
Scimed Life Systems, Inc. |
Optimally expanded, collagen sealed ePTFE graft with improved tissue ingrowth
|
|
US8128952B2
(en)
*
|
2005-01-12 |
2012-03-06 |
Clemson University Research Foundation |
Ligand-mediated controlled drug delivery
|
|
US20080207505A1
(en)
*
|
2005-01-12 |
2008-08-28 |
James Kenneth D |
Bna Conjugates and Methods of Use
|
|
WO2006102095A2
(en)
|
2005-03-18 |
2006-09-28 |
Medimmune, Inc. |
Framework-shuffling of antibodies
|
|
KR100665672B1
(ko)
*
|
2005-04-13 |
2007-01-09 |
성균관대학교산학협력단 |
새로운 온도 및 ｐＨ 민감성 블록 공중합체 및 이를 이용한고분자 하이드로겔
|
|
WO2008157379A2
(en)
|
2007-06-21 |
2008-12-24 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
|
WO2006113665A2
(en)
|
2005-04-15 |
2006-10-26 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
|
ATE532540T1
(de)
|
2005-05-04 |
2011-11-15 |
Suprapolix Bv |
Modulare bioresorbierbare oder biomedizinische biologisch aktive supramolekulare stoffe
|
|
JP2008540725A
(ja)
*
|
2005-05-04 |
2008-11-20 |
スープラポリックス ビー．ブイ． |
水素結合ヒドロゲル
|
|
US20070110757A1
(en)
|
2005-06-23 |
2007-05-17 |
Ziping Wei |
Antibody formulations having optimized aggregation and fragmentation profiles
|
|
CN103146708A
(zh)
*
|
2005-06-30 |
2013-06-12 |
Abbvie公司 |
Il-12/p40结合蛋白
|
|
DK2573114T3
(da)
|
2005-08-10 |
2016-07-04 |
Macrogenics Inc |
Identificering og fremstilling af antistoffer med en variant af Fc-regioner og fremgangsmåder til anvendelse af samme
|
|
US8362086B2
(en)
|
2005-08-19 |
2013-01-29 |
Merial Limited |
Long acting injectable formulations
|
|
EP2500358A3
(en)
|
2005-08-19 |
2012-10-17 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
US20090215992A1
(en)
*
|
2005-08-19 |
2009-08-27 |
Chengbin Wu |
Dual variable domain immunoglobulin and uses thereof
|
|
MY169746A
(en)
|
2005-08-19 |
2019-05-14 |
Abbvie Inc |
Dual variable domain immunoglobulin and uses thereof
|
|
CA2624562A1
(en)
|
2005-09-30 |
2007-04-12 |
Abbott Gmbh & Co. Kg |
Binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and their use
|
|
US20070078480A1
(en)
*
|
2005-10-04 |
2007-04-05 |
Boston Scientific Scimed, Inc. |
Self-expanding biodegradable or water-soluble vaso-occlusive devices
|
|
US20070078479A1
(en)
*
|
2005-10-04 |
2007-04-05 |
Boston Scientific Scimed, Inc. |
Self-expanding vaso-occlusive devices with regulated expansion
|
|
JP5398112B2
(ja)
*
|
2005-10-27 |
2014-01-29 |
東レ株式会社 |
生分解性粒子およびその製造方法
|
|
US20070106271A1
(en)
*
|
2005-11-09 |
2007-05-10 |
Searete Llc, A Limited Liability Corporation |
Remote control of substance delivery system
|
|
WO2007061896A1
(en)
|
2005-11-17 |
2007-05-31 |
Zogenix, Inc. |
Delivery of viscous formulations by needle-free injection
|
|
JP5475994B2
(ja)
|
2005-11-30 |
2014-04-16 |
アッヴィ・インコーポレイテッド |
抗Ａβグロブロマー抗体、その抗原結合部分、対応するハイブリドーマ、核酸、ベクター、宿主細胞、前記抗体を作製する方法、前記抗体を含む組成物、前記抗体の使用及び前記抗体を使用する方法。
|
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
|
KR100738083B1
(ko)
*
|
2005-12-20 |
2007-07-12 |
삼성전자주식회사 |
마이크로어레이용 기판 및 그의 제조방법
|
|
WO2007074604A1
(ja)
|
2005-12-26 |
2007-07-05 |
Ltt Bio-Pharma Co., Ltd. |
水溶性非ペプチド性低分子薬物含有ナノ粒子
|
|
US20070178137A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Toby Freyman |
Local control of inflammation
|
|
US20070239194A1
(en)
*
|
2006-04-05 |
2007-10-11 |
Boston Scientific Scimed, Inc. |
Vaso-occlusive devices having expandable fibers
|
|
US20070280986A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Carlos Gil |
Intra-operative coating of implants
|
|
MX2008015771A
(es)
|
2006-06-14 |
2009-01-27 |
Macrogenics Inc |
Metodos para el tratamiento de padecimientos autoinmunes usando anticuerpos monoclonales con toxicidad reducida.
|
|
EP2505209A1
(en)
|
2006-06-26 |
2012-10-03 |
MacroGenics, Inc. |
Fcgamma-RIIB-specific antibodies and methods of the use thereof
|
|
EP2064243A2
(en)
|
2006-08-28 |
2009-06-03 |
Kyowa Hakko Kirin Co., Ltd. |
Antagonistic human light-specific human monoclonal antibodies
|
|
CN101512008B
(zh)
|
2006-09-08 |
2015-04-01 |
艾伯维巴哈马有限公司 |
白介素-13结合蛋白
|
|
CA2699184A1
(en)
*
|
2006-09-22 |
2008-03-27 |
Labopharm Inc. |
Compositions and methods for ph targeted drug delivery
|
|
EP2407548A1
(en)
|
2006-10-16 |
2012-01-18 |
MedImmune, LLC |
Molecules with reduced half-lives, compositions and uses thereof
|
|
US20080138397A1
(en)
*
|
2006-10-24 |
2008-06-12 |
Aradigm Corporation |
Processes for taste-masking of inhaled formulations
|
|
JP5419699B2
(ja)
*
|
2006-10-31 |
2014-02-19 |
エボニック コーポレイション |
球状化されたポリマー粒子
|
|
ATE527305T1
(de)
*
|
2006-11-20 |
2011-10-15 |
Suprapolix Bv |
Supramolekulare polymere aus niedrigschmelzenden, leicht verarbeitbaren bausteinen
|
|
US20080176958A1
(en)
|
2007-01-24 |
2008-07-24 |
Insert Therapeutics, Inc. |
Cyclodextrin-based polymers for therapeutics delivery
|
|
US8628789B2
(en)
*
|
2007-03-23 |
2014-01-14 |
Suprapolix, B.V. |
Strong reversible hydrogels
|
|
EP2343342B1
(en)
|
2007-03-23 |
2015-09-16 |
SupraPolix B.V. |
Strong reversible hydrogels
|
|
KR100838809B1
(ko)
*
|
2007-05-03 |
2008-06-17 |
성균관대학교산학협력단 |
겔강도가 우수한 온도 및 피에치 민감성 블록 공중합체 및이의 제조방법과 이를 이용한 약물전달체
|
|
US20100129456A1
(en)
|
2007-05-14 |
2010-05-27 |
Ltt Bio-Pharma Co., Ltd. |
Sustained-release nanoparticle containing low-molecular-weight drug with negatively charged group
|
|
US20080287633A1
(en)
*
|
2007-05-18 |
2008-11-20 |
Drumheller Paul D |
Hydrogel Materials
|
|
EP1997830A1
(en)
|
2007-06-01 |
2008-12-03 |
AIMM Therapeutics B.V. |
RSV specific binding molecules and means for producing them
|
|
KR20100058509A
(ko)
|
2007-07-31 |
2010-06-03 |
메디뮨 엘엘씨 |
다중특이적 에피토프 결합 단백질 및 이의 용도
|
|
KR100941774B1
(ko)
*
|
2007-09-06 |
2010-02-11 |
성균관대학교산학협력단 |
인체안전성이 우수한 온도 및 피에치 민감성 블록공중합체및 이의 제조방법과 이를 이용한 약물전달체
|
|
AU2008345047A1
(en)
*
|
2007-12-26 |
2009-07-09 |
Gel-Del Technologies, Inc. |
Biocompatible protein particles, particle devices and methods thereof
|
|
BRPI0907046A2
(pt)
|
2008-01-18 |
2015-07-28 |
Medimmune Llc |
Anticorpo de cisteína engenheirada, ácido nucleico isolado, vetor, célula hospedeira, conjugado de anticorpo, composição farmacêutica, métodos de detecção de câncer, doenças ou distúrbios autoimunes, inflamatórios ou infecciosos em um indivíduo e de inibição de proliferação de uma célula alvo
|
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
|
JP2011518881A
(ja)
*
|
2008-04-28 |
2011-06-30 |
ゾゲニクス インコーポレーティッド |
片頭痛の治療のための製剤
|
|
CN102076355B
(zh)
|
2008-04-29 |
2014-05-07 |
Abbvie公司 |
双重可变结构域免疫球蛋白及其用途
|
|
US20100260668A1
(en)
*
|
2008-04-29 |
2010-10-14 |
Abbott Laboratories |
Dual Variable Domain Immunoglobulins and Uses Thereof
|
|
CN104558178A
(zh)
|
2008-05-09 |
2015-04-29 |
Abbvie公司 |
针对渐进性糖化终极产物受体（rage）的抗体及其用途
|
|
US9109026B2
(en)
|
2008-06-03 |
2015-08-18 |
Abbvie, Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
TW201008580A
(en)
|
2008-06-03 |
2010-03-01 |
Abbott Lab |
Dual variable domain immunoglobulin and uses thereof
|
|
EP2310376B1
(en)
*
|
2008-07-04 |
2014-11-05 |
SupraPolix B.V. |
High flow supramolecular compounds
|
|
TW201014602A
(en)
|
2008-07-08 |
2010-04-16 |
Abbott Lab |
Prostaglandin E2 binding proteins and uses thereof
|
|
JP5674654B2
(ja)
*
|
2008-07-08 |
2015-02-25 |
アッヴィ・インコーポレイテッド |
プロスタグランジンｅ２二重可変ドメイン免疫グロブリンおよびその使用
|
|
CN102143736A
(zh)
|
2008-07-17 |
2011-08-03 |
梅里亚有限公司 |
增强聚原酸酯和它们的制剂的稳定性的方法
|
|
KR100987693B1
(ko)
*
|
2008-10-20 |
2010-10-13 |
서울대학교산학협력단 |
폴리(에틸렌 글리콜)-ｂ-[폴리(Ｌ-세린)-ｇ-폴리(Ｄ,Ｌ-락티드)]의 블록공중합체 및 이를 이용한 약물전달체용 나노입자의 제조 방법
|
|
US10016534B2
(en)
|
2008-11-17 |
2018-07-10 |
Gel-Del Technologies, Inc. |
Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
|
|
RU2011127198A
(ru)
*
|
2008-12-04 |
2013-01-10 |
Эбботт Лэборетриз |
Иммуноглобулины с двойными вариабельными доменами и их применение
|
|
KR20110104032A
(ko)
|
2008-12-19 |
2011-09-21 |
마크로제닉스, 인크. |
공유결합형 디아바디 및 이의 용도
|
|
TW201035111A
(en)
|
2008-12-23 |
2010-10-01 |
Biosource Pharm Inc |
Antibiotic compositions for the treatment of gram negative infections
|
|
US20110165063A1
(en)
*
|
2009-01-29 |
2011-07-07 |
Abbott Laboratories |
Il-1 binding proteins
|
|
RU2011135768A
(ru)
*
|
2009-01-29 |
2013-03-10 |
Эбботт Лэборетриз |
Белки, связывающие il-1
|
|
US8030026B2
(en)
|
2009-02-24 |
2011-10-04 |
Abbott Laboratories |
Antibodies to troponin I and methods of use thereof
|
|
EP2403531A4
(en)
|
2009-03-05 |
2013-02-27 |
Abbott Lab |
IL-17 BINDING PROTEINS
|
|
US8283162B2
(en)
|
2009-03-10 |
2012-10-09 |
Abbott Laboratories |
Antibodies relating to PIVKAII and uses thereof
|
|
US20120134984A1
(en)
|
2009-06-01 |
2012-05-31 |
Olga Lubman |
Molecules with extended half-lives and uses thereof
|
|
AU2010270979B2
(en)
|
2009-06-22 |
2015-04-23 |
Medimmune, Llc |
Engineered Fc regions for site-specific conjugation
|
|
TWI465250B
(zh)
|
2009-08-29 |
2014-12-21 |
Abbvie Inc |
治療用之ｄｌｌ４結合蛋白質
|
|
NZ598929A
(en)
*
|
2009-09-01 |
2014-05-30 |
Abbvie Inc |
Dual variable domain immunoglobulins and uses thereof
|
|
CA2774015A1
(en)
|
2009-09-15 |
2011-03-24 |
Cerulean Pharma Inc. |
A cdp-camptothecin conjugate, particle or composition and uses thereof
|
|
US8568726B2
(en)
|
2009-10-06 |
2013-10-29 |
Medimmune Limited |
RSV specific binding molecule
|
|
PL2486141T3
(pl)
|
2009-10-07 |
2018-07-31 |
Macrogenics, Inc. |
Polipeptydy zawierające regiony fc i mające w wyniku zmian w zakresie fukozylacji ulepszoną funkcję efektorową, i sposoby zastosowania tych polipeptydów
|
|
BR112012008833A2
(pt)
|
2009-10-15 |
2015-09-08 |
Abbott Lab |
imunoglobulinas de dominio variavel duplo e usos das mesmas
|
|
UY32979A
(es)
*
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
US8420083B2
(en)
|
2009-10-31 |
2013-04-16 |
Abbvie Inc. |
Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof
|
|
CA2779496A1
(en)
|
2009-11-02 |
2011-05-05 |
The Administrators Of The Tulane Educational Fund |
Analogs of pitutary adenylate cyclase-activating polypeptide (pacap) and methods for their use
|
|
EP2498764B1
(en)
|
2009-11-09 |
2017-09-06 |
Spotlight Technology Partners LLC |
Fragmented hydrogels
|
|
NZ599524A
(en)
|
2009-11-09 |
2014-04-30 |
Spotlight Technology Partners Llc |
Polysaccharide based hydrogels
|
|
MX2012005987A
(es)
*
|
2009-11-23 |
2012-06-25 |
Cerulean Pharma Inc |
Polimeros a base de ciclodextrina para administracion terapeutica.
|
|
ES2562832T3
(es)
|
2009-12-08 |
2016-03-08 |
Abbvie Deutschland Gmbh & Co Kg |
Anticuerpos monoclonales contra la proteína RGM para su uso en el tratamiento de la degeneración de la capa de fibra nerviosa de la retina
|
|
EP2542582A4
(en)
|
2010-03-02 |
2013-12-04 |
Abbvie Inc |
THERAPEUTIC PROTEINS LINKING TO DLL4
|
|
ES2684475T3
(es)
|
2010-04-15 |
2018-10-03 |
Abbvie Inc. |
Proteínas que se unen a beta amiloide
|
|
CA2798390A1
(en)
|
2010-05-06 |
2011-11-10 |
Novartis Ag |
Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
|
|
EP2566892B1
(en)
|
2010-05-06 |
2017-12-20 |
Novartis AG |
Compositions and methods of use for therapeutic low density lipoprotein-related protein 6 (lrp6) antibodies
|
|
KR101848225B1
(ko)
|
2010-05-14 |
2018-04-12 |
애브비 인코포레이티드 |
Ｉｌ－１ 결합 단백질
|
|
EP2571525A4
(en)
|
2010-05-18 |
2016-04-27 |
Cerulean Pharma Inc |
Compositions and methods for treating autoimmune and other diseases
|
|
US8415307B1
(en)
|
2010-06-23 |
2013-04-09 |
Biosource Pharm, Inc. |
Antibiotic compositions for the treatment of gram negative infections
|
|
US20120009196A1
(en)
|
2010-07-08 |
2012-01-12 |
Abbott Laboratories |
Monoclonal antibodies against hepatitis c virus core protein
|
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
US9120862B2
(en)
|
2010-07-26 |
2015-09-01 |
Abbott Laboratories |
Antibodies relating to PIVKA-II and uses thereof
|
|
ES2667100T3
(es)
|
2010-08-02 |
2018-05-09 |
Macrogenics, Inc. |
Diacuerpos covalentes y sus usos
|
|
PE20131412A1
(es)
|
2010-08-03 |
2014-01-19 |
Abbvie Inc |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
EP3533803B1
(en)
|
2010-08-14 |
2021-10-27 |
AbbVie Inc. |
Anti-amyloid-beta antibodies
|
|
LT3333188T
(lt)
|
2010-08-19 |
2022-06-10 |
Zoetis Belgium S.A. |
Anti-ngf antikūnai ir jų panaudojimas
|
|
PL2606070T3
(pl)
|
2010-08-20 |
2017-06-30 |
Novartis Ag |
Przeciwciała dla receptora epidermalnego czynnika wzrostu 3 (her3)
|
|
EP2608803A4
(en)
|
2010-08-26 |
2014-01-15 |
Abbvie Inc |
IMMUNOGLOBULINS WITH TWO VARIABLE DOMAINS AND USES THEREOF
|
|
CN103179959A
(zh)
|
2010-10-20 |
2013-06-26 |
帝斯曼知识产权资产管理有限公司 |
含悬挂亲水基的可生物降解的组合物和相关器械
|
|
US9006386B2
(en)
|
2010-11-05 |
2015-04-14 |
Suprapolix B.V. |
Process for the preparation of a supramolecular polymer
|
|
WO2012069466A1
(en)
|
2010-11-24 |
2012-05-31 |
Novartis Ag |
Multispecific molecules
|
|
RU2587326C2
(ru)
|
2010-12-09 |
2016-06-20 |
Торэй Индастриз, Инк. |
Биоразлагаемые частицы, материал для окклюзии сосудов и способ получения биоразлагаемых частиц
|
|
JPWO2012086569A1
(ja)
|
2010-12-20 |
2014-05-22 |
東レ株式会社 |
医療用生分解性粒子及び血管塞栓材料
|
|
BR112013015944A2
(pt)
|
2010-12-21 |
2018-06-19 |
Abbvie Inc |
imunoglobulinas de domínio duplo variável il-1 alpha e beta biespecífico e seus usos.
|
|
US20120275996A1
(en)
|
2010-12-21 |
2012-11-01 |
Abbott Laboratories |
IL-1 Binding Proteins
|
|
LT2658525T
(lt)
|
2010-12-29 |
2017-12-11 |
Medincell |
Biologiškai skaidomos vaistų tiekimo kompozicijos
|
|
JP6094219B2
(ja)
|
2011-03-30 |
2017-03-15 |
東レ株式会社 |
生分解性粒子、血管塞栓材料及び生分解性粒子の製造方法
|
|
PT2699264T
(pt)
|
2011-04-20 |
2018-05-23 |
Medimmune Llc |
Anticorpos e outras moléculas que ligam b7-h1 e pd-1
|
|
WO2012162068A2
(en)
|
2011-05-21 |
2012-11-29 |
Macrogenics, Inc. |
Deimmunized serum-binding domains and their use for extending serum half-life
|
|
CN103608424B
(zh)
|
2011-06-30 |
2015-11-25 |
圣戈班磨料磨具有限公司 |
涂覆的磨料聚集体和包含其的产品
|
|
HK1198328A1
(zh)
|
2011-07-13 |
2015-04-02 |
Abbvie Inc. |
使用抗il-13抗體治療哮喘的方法和組合物
|
|
US9676854B2
(en)
|
2011-08-15 |
2017-06-13 |
Medimmune, Llc |
Anti-B7-H4 antibodies and their uses
|
|
JP2014530001A
(ja)
|
2011-09-23 |
2014-11-17 |
テクノファージ， インベスティガサン エデセンボルビメント エム ビオテクノロジア，エスエー |
抗腫瘍壊死因子−α剤及びその使用
|
|
TW201323440A
(zh)
|
2011-10-24 |
2013-06-16 |
Abbvie Inc |
抗骨硬化素（ｓｃｌｅｒｏｓｔｉｎ）之免疫結合物
|
|
BR112014013568A2
(pt)
|
2011-12-05 |
2017-06-13 |
Novartis Ag |
anticorpos para o receptor do fator de crescimento epidermal 3 (her3) direcionados para o domínio ii do her3
|
|
SG11201402783YA
(en)
|
2011-12-05 |
2014-06-27 |
Novartis Ag |
Antibodies for epidermal growth factor receptor 3 (her3)
|
|
MX356933B
(es)
|
2011-12-14 |
2018-06-20 |
Abbvie Deutschland |
Composicion y metodo para el diagnostico y tratamiento de trastornos relacionados con hierro.
|
|
CN107459576A
(zh)
|
2011-12-14 |
2017-12-12 |
艾伯维德国有限责任两合公司 |
用于诊断和治疗铁相关病症的组合物和方法
|
|
CA2859755C
(en)
|
2011-12-23 |
2021-04-20 |
Pfizer Inc. |
Engineered antibody constant regions for site-specific conjugation and methods and uses therefor
|
|
UY34558A
(es)
|
2011-12-30 |
2013-07-31 |
Abbvie Inc |
Proteínas de unión específicas duales dirigidas contra il-13 y/o il-17
|
|
MY194587A
(en)
|
2012-01-27 |
2022-12-05 |
Abbvie Inc |
Composition and method for the diagnosis and treatment of diseases associated with neurite degeneration
|
|
KR20130090950A
(ko)
|
2012-02-07 |
2013-08-16 |
성균관대학교산학협력단 |
듀얼 전이 고분자 하이드로젤 및 이의 이용
|
|
WO2013142152A1
(en)
*
|
2012-03-23 |
2013-09-26 |
Regents Of The University Of Minnesota |
Semi-solid delivery systems
|
|
WO2013146999A1
(ja)
|
2012-03-28 |
2013-10-03 |
東レ株式会社 |
生分解性材料及び生分解性材料の製造方法
|
|
WO2013146998A1
(ja)
|
2012-03-28 |
2013-10-03 |
東レ株式会社 |
生分解性材料及び生分解性材料の製造方法
|
|
ES2703540T3
(es)
|
2012-06-04 |
2019-03-11 |
Novartis Ag |
Métodos de marcación específicos del sitio y moléculas producidas de este modo
|
|
UY34905A
(es)
|
2012-07-12 |
2014-01-31 |
Abbvie Inc |
Proteínas de unión a il-1
|
|
WO2014055493A1
(en)
|
2012-10-02 |
2014-04-10 |
Cerulean Pharma Inc. |
Methods and systems for polymer precipitation and generation of particles
|
|
KR20190096459A
(ko)
|
2012-11-01 |
2019-08-19 |
애브비 인코포레이티드 |
항-ｖｅｇｆ／ｄｌｌ4 이원 가변 도메인 면역글로불린 및 이의 용도
|
|
HK1216428A1
(zh)
|
2012-11-09 |
2016-11-11 |
辉瑞公司 |
血小板衍生生长因子b之特异性抗体及其组合物和用途
|
|
AU2013361275B2
(en)
|
2012-12-19 |
2016-11-24 |
Amplimmune, Inc. |
Anti-human B7-H4 antibodies and their uses
|
|
AU2013363962B2
(en)
|
2012-12-21 |
2016-11-24 |
Amplimmune, Inc. |
Anti-H7CR antibodies
|
|
MX2015010146A
(es)
|
2013-02-08 |
2016-05-31 |
Novartis Ag |
Sitios especificos para modificar anticuerpos para hacer inmunoconjugados.
|
|
WO2014124258A2
(en)
|
2013-02-08 |
2014-08-14 |
Irm Llc |
Specific sites for modifying antibodies to make immunoconjugates
|
|
US9498532B2
(en)
|
2013-03-13 |
2016-11-22 |
Novartis Ag |
Antibody drug conjugates
|
|
WO2014143343A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbott Laboratories |
Hcv core lipid binding domain monoclonal antibodies
|
|
BR112015023355A8
(pt)
|
2013-03-14 |
2018-01-30 |
Abbott Lab |
antígenos recombinantes ns3 de hcv e mutantes dos mesmos para detecção de anticorpos aprimorada.
|
|
BR112015023239A8
(pt)
|
2013-03-14 |
2018-04-17 |
Abbott Lab |
ensaio de combinação de anticorpo-antígeno de hcv e métodos e composições para uso do mesmo
|
|
EP3611189A1
(en)
|
2013-03-14 |
2020-02-19 |
Novartis AG |
Antibodies against notch 3
|
|
JP6333943B2
(ja)
|
2013-03-15 |
2018-05-30 |
ノバルティス アーゲー |
抗体薬物コンジュゲート
|
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
|
BR112015023797A2
(pt)
|
2013-03-15 |
2017-10-24 |
Abbvie Inc |
proteínas de ligação de especificidade dupla dirigidas contra il-1b e/ou il-17
|
|
AU2014268298B2
(en)
|
2013-05-24 |
2019-01-17 |
Medlmmune, Llc |
Anti-B7-H5 antibodies and their uses
|
|
SG11201509982UA
(da)
|
2013-06-06 |
2016-04-28 |
Igenica Biotherapeutics Inc |
|
|
WO2014197885A2
(en)
|
2013-06-07 |
2014-12-11 |
Duke University |
Inhibitors of complement factor h
|
|
US11384149B2
(en)
|
2013-08-09 |
2022-07-12 |
Macrogenics, Inc. |
Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof
|
|
UA116479C2
(uk)
|
2013-08-09 |
2018-03-26 |
Макродженікс, Інк. |
БІСПЕЦИФІЧНЕ МОНОВАЛЕНТНЕ Fc-ДІАТІЛО, ЯКЕ ОДНОЧАСНО ЗВ'ЯЗУЄ CD32B I CD79b, ТА ЙОГО ЗАСТОСУВАННЯ
|
|
EP2840091A1
(en)
|
2013-08-23 |
2015-02-25 |
MacroGenics, Inc. |
Bi-specific diabodies that are capable of binding gpA33 and CD3 and uses thereof
|
|
EP2839842A1
(en)
|
2013-08-23 |
2015-02-25 |
MacroGenics, Inc. |
Bi-specific monovalent diabodies that are capable of binding CD123 and CD3 and uses thereof
|
|
WO2015058868A1
(en)
|
2013-10-25 |
2015-04-30 |
Pangaea Biotech, S.L. |
Compositions and methods for the treatment of cancer
|
|
GB201318990D0
(en)
|
2013-10-28 |
2013-12-11 |
Omg Plc |
Optical sighting
|
|
AU2014348676B2
(en)
|
2013-11-13 |
2020-06-18 |
Bristol-Myers Squibb Company |
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof
|
|
WO2015084883A2
(en)
|
2013-12-02 |
2015-06-11 |
Abbvie, Inc. |
Compositions and methods for treating osteoarthritis
|
|
WO2015109212A1
(en)
|
2014-01-17 |
2015-07-23 |
Pfizer Inc. |
Anti-il-2 antibodies and compositions and uses thereof
|
|
SI3097122T1
(sl)
|
2014-01-24 |
2020-07-31 |
Ngm Biopharmaceuticals, Inc. |
Protitelesa, ki se vežejo v domeni beta klotho 2, in metode za njihovo uporabo
|
|
JP6533534B2
(ja)
|
2014-02-14 |
2019-06-19 |
マクロジェニクス，インコーポレーテッド |
膠芽腫の治療に使用するための組成物及びその使用
|
|
WO2015127351A1
(en)
|
2014-02-24 |
2015-08-27 |
Celgene Corporation |
Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders
|
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
|
WO2015138337A1
(en)
|
2014-03-09 |
2015-09-17 |
Abbvie, Inc. |
Compositions and methods for treating rheumatoid arthritis
|
|
AU2015229463A1
(en)
|
2014-03-12 |
2016-09-15 |
Novartis Ag |
Specific sites for modifying antibodies to make immunoconjugates
|
|
CN106413750B
(zh)
|
2014-05-16 |
2022-04-29 |
免疫医疗有限责任公司 |
具有增强的治疗和诊断特性的带有改变的新生儿Fc受体结合的分子
|
|
AP2016009586A0
(en)
|
2014-05-29 |
2016-11-30 |
Macrogenics Inc |
Tri-specific binding molecules and methods of use thereof
|
|
TWI693232B
(zh)
|
2014-06-26 |
2020-05-11 |
美商宏觀基因股份有限公司 |
與pd-1和lag-3具有免疫反應性的共價結合的雙抗體和其使用方法
|
|
CN107257691B
(zh)
|
2014-07-16 |
2021-09-21 |
达娜-法勃肿瘤研究所公司 |
低级别浆液性卵巢癌中的her3抑制
|
|
US10786578B2
(en)
|
2014-08-05 |
2020-09-29 |
Novartis Ag |
CKIT antibody drug conjugates
|
|
BR112017001588A2
(pt)
|
2014-08-12 |
2017-11-21 |
Novartis Ag |
conjugados de anticorpo/fármaco anti-cdh6
|
|
WO2016048938A1
(en)
|
2014-09-26 |
2016-03-31 |
Macrogenics, Inc. |
Bi-specific monovalent diabodies that are capable of binding cd19 and cd3, and uses thereof
|
|
AU2015347015B2
(en)
|
2014-11-14 |
2019-02-14 |
Novartis Ag |
Antibody drug conjugates
|
|
SMT202200344T1
(it)
|
2014-12-09 |
2022-09-14 |
Sweetwater Energy Inc |
Pretrattamento rapido
|
|
WO2016094837A2
(en)
|
2014-12-11 |
2016-06-16 |
Igenica Biotherapeutics, Inc. |
Anti-c10orf54 antibodies and uses thereof
|
|
US10093733B2
(en)
|
2014-12-11 |
2018-10-09 |
Abbvie Inc. |
LRP-8 binding dual variable domain immunoglobulin proteins
|
|
CN104479157B
(zh)
*
|
2015-01-06 |
2017-07-11 |
山东理工大学 |
一种聚己内酯与聚乙二醇改进聚肽膜亲水性与柔顺性的方法
|
|
WO2016118921A1
(en)
|
2015-01-24 |
2016-07-28 |
Abbvie, Inc. |
Compositions and methods for treating psoriatic arthritis
|
|
RU2017129236A
(ru)
|
2015-01-26 |
2019-03-07 |
Макродженикс, Инк. |
Мультивалентные молекулы, содержащие dr5-связывающие домены
|
|
DE112016001013T5
(de)
|
2015-03-03 |
2017-12-21 |
Kymab Limited |
Antikörper, verwendungen und verfahren
|
|
PE20180193A1
(es)
|
2015-05-29 |
2018-01-26 |
Abbvie Inc |
Anticuerpos anti-cd40 y sus usos
|
|
TWI773646B
(zh)
|
2015-06-08 |
2022-08-11 |
美商宏觀基因股份有限公司 |
結合lag-3的分子和其使用方法
|
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗ｖｅｇｆ、ｐｄｇｆ及／或其受體之結合蛋白
|
|
US20190194315A1
(en)
|
2015-06-17 |
2019-06-27 |
Novartis Ag |
Antibody drug conjugates
|
|
US11066481B2
(en)
|
2015-07-23 |
2021-07-20 |
The Regents Of The University Of California |
Antibodies to coagulation factor XIa and uses thereof
|
|
SG10201906059VA
(en)
|
2015-07-30 |
2019-08-27 |
Macrogenics Inc |
Pd-1-binding molecules and methods of use thereof
|
|
US9862760B2
(en)
|
2015-09-16 |
2018-01-09 |
Novartis Ag |
Polyomavirus neutralizing antibodies
|
|
WO2017058859A1
(en)
|
2015-09-29 |
2017-04-06 |
Celgene Corporation |
Pd-1 binding proteins and methods of use thereof
|
|
CN109071648B
(zh)
|
2015-10-23 |
2022-07-19 |
辉瑞有限公司 |
抗il-2抗体及其组合物和用途
|
|
WO2017077066A1
(en)
|
2015-11-06 |
2017-05-11 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Composition comprising a biocompatible and biodegradable polymer, nanocarries and a drug and methods of making and using the same
|
|
EP4374861A3
(en)
|
2015-11-16 |
2024-08-07 |
MedinCell S.A. |
A method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
|
|
EP3909983A1
(en)
|
2015-12-02 |
2021-11-17 |
STCube & Co. Inc. |
Antibodies and molecules that immunospecifically bind to btn1a1 and the therapeutic uses thereof
|
|
JP7227007B2
(ja)
|
2015-12-02 |
2023-02-21 |
ストサイエンシス， インコーポレイテッド |
グリコシル化ｂｔｌａ（ｂ－及びｔ－リンパ球減弱因子）に特異的な抗体
|
|
CR20180318A
(es)
|
2015-12-14 |
2018-09-19 |
Macrogenics Inc |
Moléculas biespecíficas que tienen inmunorreactividad con pd-1 y ctla-4, y métodos de uso de las mismas
|
|
ES2847155T3
(es)
|
2016-01-21 |
2021-08-02 |
Novartis Ag |
Moléculas multiespecíficas que fijan como objetivo CLL-1
|
|
CN109562169A
(zh)
|
2016-06-08 |
2019-04-02 |
艾伯维公司 |
抗cd98抗体及抗体药物偶联物
|
|
WO2017214322A1
(en)
|
2016-06-08 |
2017-12-14 |
Abbvie Inc. |
Anti-b7-h3 antibodies and antibody drug conjugates
|
|
EP3835322A3
(en)
|
2016-06-08 |
2021-10-06 |
AbbVie Inc. |
Anti-b7-h3 antibodies and antibody drug conjugates
|
|
JP2019534859A
(ja)
|
2016-09-19 |
2019-12-05 |
セルジーン コーポレイション |
Ｐｄ−１結合タンパク質を使用して白斑を治療する方法
|
|
CN109952317A
(zh)
|
2016-09-19 |
2019-06-28 |
细胞基因公司 |
使用pd-1结合蛋白治疗免疫病症的方法
|
|
US11779604B2
(en)
|
2016-11-03 |
2023-10-10 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses and methods
|
|
CN117731591A
(zh)
|
2016-11-21 |
2024-03-22 |
艾里奥治疗公司 |
大试剂的透皮递送
|
|
EP3544628A4
(en)
|
2016-11-23 |
2020-11-18 |
Immunoah Therapeutics, Inc. |
4-1BB BINDING PROTEINS AND THEIR USES
|
|
JOP20190187A1
(ar)
|
2017-02-03 |
2019-08-01 |
Novartis Ag |
مترافقات عقار جسم مضاد لـ ccr7
|
|
EP3583223A4
(en)
|
2017-02-16 |
2020-12-23 |
Sweetwater Energy, Inc. |
HIGH PRESSURE ZONE TRAINING FOR PRETREATMENT
|
|
WO2018185618A1
(en)
|
2017-04-03 |
2018-10-11 |
Novartis Ag |
Anti-cdh6 antibody drug conjugates and anti-gitr antibody combinations and methods of treatment
|
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
|
EP3630835A1
(en)
|
2017-05-31 |
2020-04-08 |
STCube & Co., Inc. |
Antibodies and molecules that immunospecifically bind to btn1a1 and the therapeutic uses thereof
|
|
KR102861670B1
(ko)
|
2017-05-31 |
2025-09-18 |
주식회사 에스티큐브앤컴퍼니 |
Btn1a1에 면역특이적으로 결합하는 항체 및 분자를 사용하여 암을 치료하는 방법
|
|
JP2020522562A
(ja)
|
2017-06-06 |
2020-07-30 |
ストキューブ アンド シーオー．， インコーポレイテッド |
Ｂｔｎ１ａ１又はｂｔｎ１ａ１リガンドに結合する抗体及び分子を用いて癌を治療する方法
|
|
EP3717516A1
(en)
|
2017-12-01 |
2020-10-07 |
Pfizer Inc |
Anti-cxcr5 antibodies and compositions and uses thereof
|
|
US11433132B2
(en)
|
2017-12-01 |
2022-09-06 |
Novartis Ag |
Polyomavirus neutralizing antibodies
|
|
KR20200130696A
(ko)
|
2018-03-12 |
2020-11-19 |
조에티스 서비시즈 엘엘씨 |
항-ngf 항체 및 이의 방법
|
|
KR102826439B1
(ko)
|
2018-03-29 |
2025-06-26 |
화이자 인코포레이티드 |
Lfa3 변이체 및 그의 조성물 및 용도
|
|
US10640576B2
(en)
|
2018-04-10 |
2020-05-05 |
Y-Biologics Inc. |
Cell engaging binding molecules
|
|
EP3801766A1
(en)
|
2018-05-31 |
2021-04-14 |
Novartis AG |
Hepatitis b antibodies
|
|
US11492409B2
(en)
|
2018-06-01 |
2022-11-08 |
Novartis Ag |
Binding molecules against BCMA and uses thereof
|
|
JP2021529516A
(ja)
|
2018-06-18 |
2021-11-04 |
アンウィタ バイオサイエンシス， インク． |
サイトカイン融合タンパク質及びその使用
|
|
MA53160A
(fr)
|
2018-07-20 |
2021-05-26 |
Pf Medicament |
Récepteur pour vista
|
|
TW202024131A
(zh)
|
2018-09-07 |
2020-07-01 |
美商輝瑞大藥廠 |
抗-αvβ8抗體及組合物及其用途
|
|
WO2020053742A2
(en)
|
2018-09-10 |
2020-03-19 |
Novartis Ag |
Anti-hla-hbv peptide antibodies
|
|
AU2019349651B2
(en)
|
2018-09-27 |
2023-12-07 |
Celgene Corporation |
SIRP alpha binding proteins and methods of use thereof
|
|
EP3856244A4
(en)
|
2018-09-28 |
2022-07-20 |
Jochen Reiser |
SUPAR AND PREDICTION AND TREATMENT OF ACUTE KIDNEY LESION
|
|
TW202039554A
(zh)
|
2018-12-19 |
2020-11-01 |
瑞士商諾華公司 |
抗ＴＮＦ－α抗體
|
|
EP4406555A3
(en)
|
2018-12-21 |
2024-11-06 |
Novartis AG |
Antibodies to pmel17 and conjugates thereof
|
|
AU2020234394B2
(en)
|
2019-03-08 |
2024-02-15 |
AbTis Co., Ltd. |
Site-specific antibody conjugation and antibody-drug conjugate as specific example thereof
|
|
US12291562B2
(en)
|
2019-04-01 |
2025-05-06 |
Rush University Medical Center |
Reagents and assays using modified integrin domains
|
|
TW202102526A
(zh)
|
2019-04-04 |
2021-01-16 |
美商銳進科斯生物股份有限公司 |
重組腺相關病毒及其用途
|
|
JP2022544004A
(ja)
|
2019-07-26 |
2022-10-17 |
リジェネックスバイオ インコーポレイテッド |
操作された核酸調節エレメントならびにその使用方法
|
|
JP2022549504A
(ja)
|
2019-09-26 |
2022-11-25 |
エスティーキューブ アンド カンパニー |
グリコシル化ｃｔｌａ－４に対して特異的な抗体およびその使用方法
|
|
CN110615829B
(zh)
*
|
2019-09-29 |
2022-07-19 |
深圳市三浦天然化妆品有限公司 |
一种自组装抗菌肽水凝胶
|
|
CN114829404B
(zh)
|
2019-10-09 |
2025-09-09 |
斯特库比公司 |
对糖基化的lag3特异的抗体及其使用方法
|
|
AU2020412611A1
(en)
|
2019-12-22 |
2022-07-14 |
Apalta Patents OÜ |
Methods of making specialized lignin and lignin products from biomass
|
|
US20230181756A1
(en)
|
2020-04-30 |
2023-06-15 |
Novartis Ag |
Ccr7 antibody drug conjugates for treating cancer
|
|
EP4143236A1
(en)
|
2020-05-01 |
2023-03-08 |
Novartis AG |
Engineered immunoglobulins
|
|
EP4143224A1
(en)
|
2020-05-01 |
2023-03-08 |
Novartis AG |
Immunoglobulin variants
|
|
WO2021231798A1
(en)
|
2020-05-13 |
2021-11-18 |
Disc Medicine, Inc. |
Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis
|
|
IL298909A
(en)
|
2020-06-17 |
2023-02-01 |
Janssen Biotech Inc |
Materials and methods for the manufacture of pluripotent stem cells
|
|
TW202212354A
(zh)
|
2020-08-03 |
2022-04-01 |
美商健生生物科技公司 |
用於病毒治療劑中之多向生物運輸的材料及方法
|
|
JP2023536346A
(ja)
|
2020-08-05 |
2023-08-24 |
エリプシーズ ファーマ リミテッド |
シクロデキストリン含有ポリマートポイソメラーゼ阻害剤コンジュゲートおよびｐａｒｐ阻害剤を用いた癌の処置
|
|
MX2023001708A
(es)
|
2020-08-10 |
2023-05-04 |
Janssen Biotech Inc |
Materiales y métodos para producir linfocitos específicos de virus diseñados mediante bioingeniería.
|
|
WO2022076750A2
(en)
|
2020-10-07 |
2022-04-14 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for cns or muscle delivery
|
|
JP2023545722A
(ja)
|
2020-10-07 |
2023-10-31 |
リジェネックスバイオ インコーポレイテッド |
遺伝子治療剤の眼送達のためのアデノ随伴ウイルス
|
|
US12383246B2
(en)
|
2020-10-12 |
2025-08-12 |
Abbott Cardiovascular Systems, Inc. |
Vessel closure device with improved safety and tract hemostasis
|
|
WO2022097061A1
(en)
|
2020-11-06 |
2022-05-12 |
Novartis Ag |
Anti-cd19 agent and b cell targeting agent combination therapy for treating b cell malignancies
|
|
EP4240491A1
(en)
|
2020-11-06 |
2023-09-13 |
Novartis AG |
Cd19 binding molecules and uses thereof
|
|
WO2022097065A2
(en)
|
2020-11-06 |
2022-05-12 |
Novartis Ag |
ANTIBODY Fc VARIANTS
|
|
WO2022147463A2
(en)
|
2020-12-31 |
2022-07-07 |
Alamar Biosciences, Inc. |
Binder molecules with high affinity and/ or specificity and methods of making and use thereof
|
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
|
GB202103785D0
(en)
*
|
2021-03-18 |
2021-05-05 |
UCB Biopharma SRL |
Formulations
|
|
WO2022221720A1
(en)
|
2021-04-16 |
2022-10-20 |
Novartis Ag |
Antibody drug conjugates and methods for making thereof
|
|
CN113354800A
(zh)
*
|
2021-06-22 |
2021-09-07 |
山东谷雨春生物科技有限公司 |
一种peg嵌段聚乙丙交酯及其应用
|
|
WO2023060269A1
(en)
|
2021-10-07 |
2023-04-13 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for targeted delivery
|
|
EP4413019A2
(en)
|
2021-10-07 |
2024-08-14 |
RegenxBio Inc. |
Recombinant adeno-associated viruses for cns tropic delivery
|
|
US20250025574A1
(en)
|
2021-10-28 |
2025-01-23 |
Regenxbio Inc. |
Engineered nucleic acid regulatory elements and methods and uses thereof
|
|
CN118119642A
(zh)
|
2021-10-28 |
2024-05-31 |
诺华股份有限公司 |
工程化Fc变体
|
|
UY40097A
(es)
|
2022-01-07 |
2023-07-14 |
Johnson & Johnson Entpr Innovation Inc |
Materiales y métodos de proteínas de unión a il-1b
|
|
AU2023217968A1
(en)
|
2022-02-09 |
2024-09-26 |
Janssen Biotech, Inc. |
Methods and compositions comprising v beta 17 bispecific t cell engagers and bioengineered virus specific lymphocytes
|
|
KR102707065B1
(ko)
|
2022-03-08 |
2024-09-19 |
동국제약 주식회사 |
코아세르베이션법을 이용하여 현탁성이 개선된 미립구의 제조방법
|
|
TW202346590A
(zh)
|
2022-03-13 |
2023-12-01 |
美商銳進科斯生物股份有限公司 |
經修飾之肌肉特異性啟動子
|
|
WO2023201277A1
(en)
|
2022-04-14 |
2023-10-19 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for cns tropic delivery
|
|
US20250249127A1
(en)
|
2022-04-14 |
2025-08-07 |
Regenxbio Inc. |
Gene therapy for treating an ocular disease
|
|
WO2023205610A2
(en)
|
2022-04-18 |
2023-10-26 |
Regenxbio Inc. |
Hybrid aav capsids
|
|
CA3255838A1
(en)
|
2022-04-26 |
2023-11-02 |
Novartis Ag |
MULTISPECIFIC ANTIBODIES TARGETTING IL-13 AND IL-18
|
|
JP2025525530A
(ja)
|
2022-07-15 |
2025-08-05 |
ヤンセン バイオテツク，インコーポレーテツド |
抗原結合可変領域の改善された生物工学による対合のための材料及び方法
|
|
EP4558151A1
(en)
|
2022-07-22 |
2025-05-28 |
Janssen Biotech, Inc. |
Enhanced transfer of genetic instructions to effector immune cells
|
|
CA3263779A1
(en)
|
2022-08-05 |
2024-02-08 |
Janssen Biotech, Inc. |
CD98 LINKAGE CONSTRUCTIONS FOR THE TREATMENT OF BRAIN TUMORS
|
|
EP4565330A1
(en)
|
2022-08-05 |
2025-06-11 |
Janssen Biotech, Inc. |
Transferrin receptor binding proteins for treating brain tumors
|
|
JP2025527658A
(ja)
|
2022-08-24 |
2025-08-22 |
リジェネックスバイオ インコーポレイテッド |
組換えアデノ随伴ウイルス及びその使用
|
|
JP2025534666A
(ja)
|
2022-10-11 |
2025-10-17 |
リジェネックスバイオ インコーポレイテッド |
操作された核酸調節エレメントならびにその使用方法
|
|
TW202448505A
(zh)
|
2023-03-01 |
2024-12-16 |
美商普泛森生技公司 |
用於治療第1型糖尿病的方法及組成物
|
|
TW202506177A
(zh)
|
2023-03-30 |
2025-02-16 |
美商普泛森生技公司 |
減少外源性胰島素使用之方法
|
|
WO2024216244A2
(en)
|
2023-04-13 |
2024-10-17 |
Regenxbio Inc. |
Targeting aav capsids, methods of manufacturing and using same
|
|
WO2024238853A1
(en)
|
2023-05-16 |
2024-11-21 |
Regenxbio Inc. |
Adeno-associated viruses for ocular delivery of gene therapy
|
|
TW202521153A
(zh)
|
2023-07-27 |
2025-06-01 |
美商普泛森生技公司 |
治療第1型糖尿病之方法
|
|
WO2025108407A2
(en)
|
2023-11-23 |
2025-05-30 |
Neuexcell Therapeutics (Suzhou) Co., Ltd. |
Gene therapy compositions and methods for treating glioma
|
|
WO2025217214A2
(en)
|
2024-04-08 |
2025-10-16 |
Regenxbio Inc. |
Recombinant adeno-associated viruses and uses thereof
|
|
WO2025262564A1
(en)
|
2024-06-17 |
2025-12-26 |
Pfizer Inc. |
Use of anti-cxcr5 antibodies
|